Annual CFF
$49.14 M
+$49.38 M+20490.04%
December 31, 2023
Summary
- As of February 12, 2025, SPRB annual cash flow from financing activities is $49.14 million, with the most recent change of +$49.38 million (+20490.04%) on December 31, 2023.
- During the last 3 years, SPRB annual CFF has fallen by -$131.90 million (-72.86%).
- SPRB annual CFF is now -72.86% below its all-time high of $181.03 million, reached on December 31, 2020.
Performance
SPRB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$405.00 K
-$40.00 K-10.96%
September 30, 2024
Summary
- As of February 12, 2025, SPRB quarterly cash flow from financing activities is -$405.00 thousand, with the most recent change of -$40.00 thousand (-10.96%) on September 30, 2024.
- Over the past year, SPRB quarterly CFF has increased by +$147.00 thousand (+26.63%).
- SPRB quarterly CFF is now -100.43% below its all-time high of $94.28 million, reached on December 31, 2020.
Performance
SPRB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$1.55 M
$0.000.00%
September 30, 2024
Summary
- As of February 12, 2025, SPRB TTM cash flow from financing activities is -$1.55 million, unchanged on September 30, 2024.
- Over the past year, SPRB TTM CFF has dropped by -$50.69 million (-103.15%).
- SPRB TTM CFF is now -100.86% below its all-time high of $181.03 million, reached on December 31, 2020.
Performance
SPRB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
SPRB Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | +26.6% | -103.2% |
| 3 y3 years | -72.9% | +26.6% | -103.2% |
| 5 y5 years | +100.0% | +26.6% | -103.2% |
SPRB Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -100.8% | +26.6% | -103.1% | +4.2% |
| 5 y | 5-year | -72.9% | >+9999.0% | -100.4% | +26.6% | -100.9% | +4.2% |
| alltime | all time | -72.9% | >+9999.0% | -100.4% | +26.6% | -100.9% | +4.2% |
Spruce Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$405.00 K(+11.0%) | -$1.55 M(0.0%) |
| Jun 2024 | - | -$365.00 K(+60.8%) | -$1.55 M(-4.1%) |
| Mar 2024 | - | -$227.00 K(-58.9%) | -$1.62 M(-103.3%) |
| Dec 2023 | $49.14 M(<-9900.0%) | -$552.00 K(+36.3%) | $49.14 M(-1.2%) |
| Sep 2023 | - | -$405.00 K(-6.3%) | $49.73 M(-0.6%) |
| Jun 2023 | - | -$432.00 K(-100.9%) | $50.04 M(-0.7%) |
| Mar 2023 | - | $50.53 M(>+9900.0%) | $50.38 M(<-9900.0%) |
| Dec 2022 | -$241.00 K | $36.00 K(-140.0%) | -$241.00 K(+119.1%) |
| Sep 2022 | - | -$90.00 K(-9.1%) | -$110.00 K(+3566.7%) |
| Jun 2022 | - | -$99.00 K(+12.5%) | -$3000.00(-101.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$88.00 K(-152.7%) | $272.00 K(-57.7%) |
| Dec 2021 | $643.00 K(-99.6%) | $167.00 K(+882.4%) | $643.00 K(-99.3%) |
| Sep 2021 | - | $17.00 K(-90.3%) | $94.76 M(-31.3%) |
| Jun 2021 | - | $176.00 K(-37.8%) | $137.94 M(+0.2%) |
| Mar 2021 | - | $283.00 K(-99.7%) | $137.66 M(-24.0%) |
| Dec 2020 | $181.03 M(+1356.1%) | $94.28 M(+118.3%) | $181.03 M(+108.7%) |
| Sep 2020 | - | $43.20 M(<-9900.0%) | $86.75 M(+99.2%) |
| Jun 2020 | - | -$99.00 K(-100.2%) | $43.56 M(-0.2%) |
| Mar 2020 | - | $43.66 M | $43.66 M |
| Dec 2019 | $12.43 M(>+9900.0%) | - | - |
| Dec 2018 | $0.00 | - | - |
FAQ
- What is Spruce Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for Spruce Biosciences?
- What is Spruce Biosciences annual CFF year-on-year change?
- What is Spruce Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Spruce Biosciences?
- What is Spruce Biosciences quarterly CFF year-on-year change?
- What is Spruce Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Spruce Biosciences?
- What is Spruce Biosciences TTM CFF year-on-year change?
What is Spruce Biosciences annual cash flow from financing activities?
The current annual CFF of SPRB is $49.14 M
What is the all time high annual CFF for Spruce Biosciences?
Spruce Biosciences all-time high annual cash flow from financing activities is $181.03 M
What is Spruce Biosciences annual CFF year-on-year change?
Over the past year, SPRB annual cash flow from financing activities has changed by +$49.38 M (+20490.04%)
What is Spruce Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of SPRB is -$405.00 K
What is the all time high quarterly CFF for Spruce Biosciences?
Spruce Biosciences all-time high quarterly cash flow from financing activities is $94.28 M
What is Spruce Biosciences quarterly CFF year-on-year change?
Over the past year, SPRB quarterly cash flow from financing activities has changed by +$147.00 K (+26.63%)
What is Spruce Biosciences TTM cash flow from financing activities?
The current TTM CFF of SPRB is -$1.55 M
What is the all time high TTM CFF for Spruce Biosciences?
Spruce Biosciences all-time high TTM cash flow from financing activities is $181.03 M
What is Spruce Biosciences TTM CFF year-on-year change?
Over the past year, SPRB TTM cash flow from financing activities has changed by -$50.69 M (-103.15%)